3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia
11
Prostatic Neoplasms
10
Lymphoma
9
Leukemia, Monocytic, Acute
8
Leukemia, Erythroblastic, Acute
8
Leukemia, Myelomonocytic, Acute
7
Congenital Abnormalities
7
Lymphoma, Follicular
6
Leukemia, Megakaryoblastic, Acute
6
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Leukemia, Biphenotypic, Acute
5
Recurrence
3
Sarcoma, Myeloid
2
Neoplasms
2
Myeloproliferative Disorders
2
Lymphoma, Mantle-Cell
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Eosinophilic, Acute
2
Leukemia, Basophilic, Acute
2
Waldenstrom Macroglobulinemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Myeloid Malignancies
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, T-Cell
1
Interventions
Pemetrexed
12
Cisplatin
11
pembrolizumab
8
Carboplatin
6
Ipilimumab
5
Nivolumab
4
LMB-100
4
durvalumab
3
Gemcitabine
3
tremelimumab
2
tazemetostat
2
anetumab ravtansine
2
Vinorelbine
2
Plicamycin
2
Dexamethasone
2
Cyclophosphamide
2
Bevacizumab
2
vandetanib
1
tocilizumab
1
spartalizumab
1
ribociclib
1
rebastinib
1
pevonedistat
1
olaparib
1
niraparib
1
nintedanib
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
enzalutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma
×
Mitoxantrone
×
Clear all
No trials found.